These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 22729371)
21. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Simonet WS; Lacey DL; Dunstan CR; Kelley M; Chang MS; Lüthy R; Nguyen HQ; Wooden S; Bennett L; Boone T; Shimamoto G; DeRose M; Elliott R; Colombero A; Tan HL; Trail G; Sullivan J; Davy E; Bucay N; Renshaw-Gegg L; Hughes TM; Hill D; Pattison W; Campbell P; Sander S; Van G; Tarpley J; Derby P; Lee R; Boyle WJ Cell; 1997 Apr; 89(2):309-19. PubMed ID: 9108485 [TBL] [Abstract][Full Text] [Related]
22. Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats. Valenta A; Roschger P; Fratzl-Zelman N; Kostenuik PJ; Dunstan CR; Fratzl P; Klaushofer K Bone; 2005 Jul; 37(1):87-95. PubMed ID: 15869920 [TBL] [Abstract][Full Text] [Related]
23. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption. Sasaki T Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416 [TBL] [Abstract][Full Text] [Related]
24. Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosis. Bolon B; Carter C; Daris M; Morony S; Capparelli C; Hsieh A; Mao M; Kostenuik P; Dunstan CR; Lacey DL; Sheng JZ Mol Ther; 2001 Feb; 3(2):197-205. PubMed ID: 11237676 [TBL] [Abstract][Full Text] [Related]
25. Bu-Shen-Tong-Luo decoction prevents bone loss via inhibition of bone resorption and enhancement of angiogenesis in ovariectomy-induced osteoporosis of rats. Yuan H; Xiao L; Min W; Yuan W; Lu S; Huang G J Ethnopharmacol; 2018 Jun; 220():228-238. PubMed ID: 29317302 [TBL] [Abstract][Full Text] [Related]
26. Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption. Peng S; Liu XS; Zhou G; Li Z; Luk KD; Guo XE; Lu WW J Bone Miner Res; 2011 Jun; 26(6):1272-82. PubMed ID: 21611968 [TBL] [Abstract][Full Text] [Related]
27. RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats. Ominsky MS; Li X; Asuncion FJ; Barrero M; Warmington KS; Dwyer D; Stolina M; Geng Z; Grisanti M; Tan HL; Corbin T; McCabe J; Simonet WS; Ke HZ; Kostenuik PJ J Bone Miner Res; 2008 May; 23(5):672-82. PubMed ID: 18433301 [TBL] [Abstract][Full Text] [Related]
28. Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice. Kostenuik PJ; Bolon B; Morony S; Daris M; Geng Z; Carter C; Sheng J Bone; 2004 Apr; 34(4):656-64. PubMed ID: 15050896 [TBL] [Abstract][Full Text] [Related]
30. Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice. Yamazaki H; Sasaki T J Electron Microsc (Tokyo); 2005 Oct; 54(5):467-77. PubMed ID: 16339792 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and disposition of recombinant human osteoprotegerin (rhOPG) after intravenous administration in female fischer rats. Miyaji Y; Kurihara A; Kamiyama E; Shiiki T; Kawai K; Okazaki O Xenobiotica; 2009 Feb; 39(2):113-24. PubMed ID: 19255937 [TBL] [Abstract][Full Text] [Related]
32. PEGylation of an osteoclast inhibitory peptide: suitable candidate for the treatment of osteoporosis. Akhtar J; Mallaredy V; Dandapat J; Maiti P; Sahoo SK; Singh S Int J Pharm; 2012 Sep; 434(1-2):429-36. PubMed ID: 22698865 [TBL] [Abstract][Full Text] [Related]
33. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR. Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663 [TBL] [Abstract][Full Text] [Related]
34. Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. Kostenuik PJ; Shalhoub V Curr Pharm Des; 2001 May; 7(8):613-35. PubMed ID: 11375772 [TBL] [Abstract][Full Text] [Related]
35. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice. Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235 [TBL] [Abstract][Full Text] [Related]
36. Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment. Ochiai N; Nakachi Y; Yokoo T; Ichihara T; Eriksson T; Yonemoto Y; Kato T; Ogata H; Fujimoto N; Kobayashi Y; Udagawa N; Kaku S; Ueki T; Okazaki Y; Takahashi N; Suda T Commun Biol; 2019; 2():86. PubMed ID: 30854478 [TBL] [Abstract][Full Text] [Related]
37. Effect of Rehmannia glutinosa Libosch extracts on bone metabolism. Oh KO; Kim SW; Kim JY; Ko SY; Kim HM; Baek JH; Ryoo HM; Kim JK Clin Chim Acta; 2003 Aug; 334(1-2):185-95. PubMed ID: 12867291 [TBL] [Abstract][Full Text] [Related]
38. Genistein and Silicon Synergistically Protects Against Ovariectomy-Induced Bone Loss Through Upregulating OPG/RANKL Ratio. Chen C; Zheng H; Qi S Biol Trace Elem Res; 2019 Apr; 188(2):441-450. PubMed ID: 30014283 [TBL] [Abstract][Full Text] [Related]
39. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. Burgess TL; Qian Y; Kaufman S; Ring BD; Van G; Capparelli C; Kelley M; Hsu H; Boyle WJ; Dunstan CR; Hu S; Lacey DL J Cell Biol; 1999 May; 145(3):527-38. PubMed ID: 10225954 [TBL] [Abstract][Full Text] [Related]
40. A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation. Curl L; Barker C; Dreyer C; Sampson W Aust Orthod J; 2012 Nov; 28(2):219-24. PubMed ID: 23304971 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]